115 related articles for article (PubMed ID: 2946694)
21. The minimum surface fibrinogen concentration necessary for platelet activation on dimethyldichlorosilane-coated glass.
Park K; Mao FW; Park H
J Biomed Mater Res; 1991 Mar; 25(3):407-20. PubMed ID: 2026644
[TBL] [Abstract][Full Text] [Related]
22. Plasma protein adsorption to hemodialysis membranes: studies in an in vitro model.
Parzer S; Balcke P; Mannhalter C
J Biomed Mater Res; 1993 Apr; 27(4):455-63. PubMed ID: 8463348
[TBL] [Abstract][Full Text] [Related]
23. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
[TBL] [Abstract][Full Text] [Related]
24. Protein-resistant and fibrinolytic polyurethane surfaces.
Wu Z; Chen H; Liu X; Brash JL
Macromol Biosci; 2012 Jan; 12(1):126-31. PubMed ID: 21998081
[TBL] [Abstract][Full Text] [Related]
25. Lysine-PEG-modified polyurethane as a fibrinolytic surface: Effect of PEG chain length on protein interactions, platelet interactions and clot lysis.
Li D; Chen H; Glenn McClung W; Brash JL
Acta Biomater; 2009 Jul; 5(6):1864-71. PubMed ID: 19342321
[TBL] [Abstract][Full Text] [Related]
26. Transient adsorption of fibrinogen on foreign surfaces: similar behavior in plasma and whole blood.
Brash JL; ten Hove P
J Biomed Mater Res; 1989 Feb; 23(2):157-69. PubMed ID: 2708407
[TBL] [Abstract][Full Text] [Related]
27. On the role of plasmin in the catabolism of plasma proteins.
Bocci V; Pessina GP
Arch Sci Biol (Bologna); 1970; 54(1):45-56. PubMed ID: 4253721
[No Abstract] [Full Text] [Related]
28. Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface.
Andersson J; Ekdahl KN; Lambris JD; Nilsson B
Biomaterials; 2005 May; 26(13):1477-85. PubMed ID: 15522749
[TBL] [Abstract][Full Text] [Related]
29. Fibrinogen heterogeneity in homozygous plasminogen deficiency type I: further evidence that plasmin is not involved in formation of LMW- and LMW'-fibrinogen.
Dempfle CE; Pfitzner SA; Schott D; Niessen KH; Heene DL
Thromb Haemost; 1997 May; 77(5):879-83. PubMed ID: 9184396
[TBL] [Abstract][Full Text] [Related]
30. Streptokinase-dependent potentiating factor (SK-potentiator) for plasminogen activation from human plasma: its identification as a fibrinogen degradation product.
Hishikawa-Itoh Y; Sugie I; Kato H; Iwanaga S
J Biochem; 1982 Oct; 92(4):1129-40. PubMed ID: 6890955
[TBL] [Abstract][Full Text] [Related]
31. Identification of plasma proteins facilitated by enrichment on particulate surfaces: analysis by two-dimensional electrophoresis and N-terminal microsequencing.
Lück M; Schröder W; Harnisch S; Thode K; Blunk T; Paulke BR; Kresse M; Müller RH
Electrophoresis; 1997 Dec; 18(15):2961-7. PubMed ID: 9504836
[TBL] [Abstract][Full Text] [Related]
32. Interactions of antithrombin and proteins in the plasma contact activation system with immobilized functional heparin.
Cornelius RM; Sanchez J; Olsson P; Brash JL
J Biomed Mater Res A; 2003 Nov; 67(2):475-83. PubMed ID: 14566788
[TBL] [Abstract][Full Text] [Related]
33. Mass action effects on competitive adsorption of fibrinogen from hemoglobin solutions and from plasma.
Horbett TA
Thromb Haemost; 1984 Apr; 51(2):174-81. PubMed ID: 6740550
[TBL] [Abstract][Full Text] [Related]
34. Exposure of plasma proteins on Dacron and ePTFE vascular graft material in a perfusion model.
Falkenback D; Lundberg F; Ribbe E; Ljungh A
Eur J Vasc Endovasc Surg; 2000 May; 19(5):468-75. PubMed ID: 10828226
[TBL] [Abstract][Full Text] [Related]
35. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.
Nielsen VG; Cohen BM; Cohen E
Acta Anaesthesiol Scand; 2005 Feb; 49(2):222-31. PubMed ID: 15715625
[TBL] [Abstract][Full Text] [Related]
36. Procoagulant activity of surface-immobilized Hageman factor.
Chatterjee K; Vogler EA; Siedlecki CA
Biomaterials; 2006 Nov; 27(33):5643-50. PubMed ID: 16905185
[TBL] [Abstract][Full Text] [Related]
37. Soluble fibrin complexes and fibrinogen heterogeneity in diabetes mellitus.
Tsianos EB; Stathakis NE
Thromb Haemost; 1980 Dec; 44(3):130-4. PubMed ID: 6162208
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of transient adsorption of fibrinogen from plasma to solid surfaces: role of the contact and fibrinolytic systems.
Brash JL; Scott CF; ten Hove P; Wojciechowski P; Colman RW
Blood; 1988 Apr; 71(4):932-9. PubMed ID: 2965606
[TBL] [Abstract][Full Text] [Related]
39. [Immunochemical identification of proteins adsorbed on columns of activated charcoal during hemosorption in patients with psoriasis].
Petrunin DD; Molodenkov MN; Olefirenko GA
Vopr Med Khim; 1982; 28(6):33-7. PubMed ID: 6818763
[TBL] [Abstract][Full Text] [Related]
40. [Study on adsorption of human serum protein to biomaterials].
Akagi K
Kanagawa Shigaku; 1989 Sep; 24(2):345-57. PubMed ID: 2489654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
